LSTA
Lisata Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for advanced solid tumors, with a pipeline centered on tumor-penetrating delivery and targeted cancer treatments. The company emphasizes CendR Platform technology and CD34+ cell-based approaches to enhance drug delivery and modulate the tumor microenvironment. Headquartered in the United States (Basking Ridge, New Jersey), Lisata operates a broad research and development program targeting pancreatic cancer, cholangiocarcinoma, and other solid tumors.
No recent news for this company.